T. Rowe Price Investment Management, Inc. Insmed Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Insmed Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,982,707 shares of INSM stock, worth $138 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,982,707
Previous 2,277,143
12.93%
Holding current value
$138 Million
Previous $166 Million
17.65%
% of portfolio
0.08%
Previous 0.1%
Shares
10 transactions
Others Institutions Holding INSM
# of Institutions
502Shares Held
188MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.27 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$992 Million0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$901 Million84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$883 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$495 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.42B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...